Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Introduction: T cell checkpoint inhibitors targeting Programmed cell Death protein-1 (PD-1) have emerged as novel immunotherapy agents showing remarkable efficacy in head and neck squamous cell carcinoma (HNSCC). Despite important clinical benefits, they are associated with side effects that occur a...

Descripción completa

Detalles Bibliográficos
Autores principales: Spathas, Nikolaos, Economopoulou, Panagiota, Cheila, Myrto, Kotsantis, Ioannis, Fanouriakis, Antonis, Kassara, Dimitra, Psyrri, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168664/
https://www.ncbi.nlm.nih.gov/pubmed/30319973
http://dx.doi.org/10.3389/fonc.2018.00409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168664/
https://www.ncbi.nlm.nih.gov/pubmed/30319973
http://dx.doi.org/10.3389/fonc.2018.00409

Ejemplares similares